Raymond James Financial Services Advisors, Inc. Cytokinetics Inc Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$7.95 - $11.84 $208,321 - $310,255	-26,204 Closed	0 $0
Q3 2019 Nov 07, 2019	SELL	$10.82 - $14.25 $4,814 - $6,341	-445 Reduced 1.67%	26,204 $298,000
Q2 2019 Aug 06, 2019	BUY	$7.95 - $11.25 $211,859 - $299,801	26,649 New	26,649 $300,000

Others Institutions Holding CYTK

# of Institutions

410

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

Black Rock Inc. New York, NY

14.7M
Shares

$742 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$595 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

9.69M
Shares

$490 Million
0.31% of portfolio
Wellington Management Group LLP Boston, MA

7.77M
Shares

$393 Million
0.07% of portfolio
State Street Corp Boston, MA

6.46M
Shares

$326 Million
0.01% of portfolio

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.76B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account